Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.675
-0.077 (-4.42%)
At close: Jun 27, 2025, 4:00 PM
1.700
+0.025 (1.49%)
After-hours: Jun 27, 2025, 7:50 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $9.27 million as of June 27, 2025. Its market cap has decreased by -61.31% in one year.
Market Cap
9.27M
Enterprise Value
-10.01M
1-Year Change
-61.31%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $9.27M, a decrease of -51.07%. That is a compound annual growth rate of -20.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 9.69M | -45.79% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |